最近一段时间，海外手游下载增长榜冒出了几款画风清奇的产品。 其中就有合成游戏《Meme Merge: Drop Puzzle》《Merge Fellas》《Brainroot Merge Battle》、益智游戏《Brain Rotted TipTap Challenge》以及AR跳舞+DIY 音乐游戏《Animal Soundboard & AR》。差不多从今年5月开始，这五款产品纷纷闯进多国免费榜前列，截至目前下载量合计突破5300万次。 | | | | 存下载增长榜 App Store + Google Play | | | | | --- | --- | --- | --- | --- | --- | --- | | | | | 制图:游戏新知 | | | | | 排名 | icon | 游戏名称 | 增长 | 累计下载 | 玩法 | 商 | | 1 | | Meme Merge: Drop Puzzle | 1511 | 1512 | 合成 | Bravestars | | 2 | | Merge Fellas | 1393 | 1396 | 合成 | TapMen | | 3 | 25 | Bra ...

RBC Capital analyst Steven Shemesh maintained CarMax KMX with an Outperform and raised the price target from $80 to $81 on Friday.CarMax reported first-quarter earnings per share of $1.38, beating the analyst consensus estimate of $1.21. Quarterly sales of $7.55 billion outpaced the analyst consensus estimate of $7.47 billion.Also Read: CarMax Loan Delinquencies Tick Higher In May, Signaling Renewed Credit StrainRetail used unit sales rose by 9.0%, while comparable store used unit sales grew by 8.1%. Wholes ...

Core Insights - Teva Pharmaceutical Industries Ltd. announced the final analysis of the PEARL Phase 4 migraine prevention study, demonstrating that AJOVY (fremanezumab) showed sustained effectiveness over a two-year period in reducing migraine frequency, duration, and severity [1][3] Study Overview - The PEARL study was a 24-month real-world observational study involving 1,140 patients, predominantly female (87.25%), with 33.1% having episodic migraine (EM) and 66.9% chronic migraine (CM) [2][3] - The primary endpoint was a ≥50% reduction in Monthly Migraine Days (MMD) during the first 6 months of treatment, with secondary endpoints including mean change from baseline in MMD and treatment adherence [2] Effectiveness and Adherence - Over 66% of patients with EM and 51.6% with CM achieved the primary endpoint and benefitted from sustained migraine prevention for over 24 months [1][3] - Injection adherence rates remained high at approximately 90%, with over 75% (854 out of 1,129) of participants completing the study duration [1][3] Safety and Tolerability - The final analysis confirmed the favorable long-term safety and tolerability of fremanezumab, consistent with its known safety profile from previous studies [1][3] - The data supports the continued clinical use of fremanezumab for migraine prevention, particularly in populations with high disease impact [1][3] Clinical Implications - The findings underscore the importance of real-world studies in shaping clinical practice and highlight the critical role of CGRP-pathway therapies in improving patient outcomes, especially given that migraine is the second leading cause of disability worldwide [1][3]

Flash | 17 Jun 2025 10:01:01 ET │ 9 pages – 1Q market up > 50% YoY to $134bn, driven by accelerated server spend; servers >50% of DC capex, accelerated > general purpose US Communications Equipment Dell'Oro 1Q25 Data Center Capex Report Highlights CITI'S TAKE We summarize key points from Dell'Oro Group's 1Q data center capex report. – General purpose infrastructure was up modestly – Limited impact from tariff-except components. System vendors and hyperscale cloud SPs increased component inventory purchases ...

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today is joining with the Alzheimer’s disease advocacy community to raise awareness of the growing impact of Alzheimer’s disease in the United States and the importance of brain health during this year’s Alzheimer’s & Brain Awareness Month. “Alzheimer’s & Brain Awareness Month offers the perfect opportunity for all Ame ...

RT Sawyer Merritt (@SawyerMerritt)Tesla: Saving lives with Full Self-DrivingNeuralink: Improving lives with game-changing brain chipsSpaceX/Starlink: Enriching lives with first-time or better internet connectivityxAI/Grok: Empowering lives with AIX: Providing people with information, real-time news, etcA Muskonmy currently valued at a combined $1.5 trillion. ...

"The next Neuralink product is BlindSight which will enable people who have lost both eyes or have no eye sight to see."Elon Muskhttps://t.co/uv8ExkuGrU ...

热点方面，固态电池概念快速拉升，海科新源20%涨停，科恒股份涨超12%，诺德股份三连板，湘潭电化、盛新锂能涨停，天力锂能、中材科技等跟涨。 消息面上，第五届中国国际固态电池科技大会暨2025先进电池材料与智能装备技术展于6月19日至20日在合肥举办。 数字货币概念继续走强，北信源盘中涨超15%；东信和平10%涨停，年初至今已上涨72%；电科网安、宇信科技等涨幅居前。消息面上，6月18日的2025陆 家嘴论坛开幕式上，中国人民银行行长潘功胜宣布设立数字人民币国际运营中心。 脑机接口概念继续活跃，创新医疗涨停，爱朋医疗盘中涨超6%，南京熊猫、汉威科技等涨幅居前。 【大河财立方消息】大河财立方记者梳理，6月19日，A股三大股指低开，沪指跌0.13％，深证成指跌0.19％，创业板指跌0.27％。随后指数持续向下震 荡。截至10:35发稿，全市场超过3850只股票下跌。 板块方面，锂电电解液、锂电正极、宇树机器人、半导体设备、汽车配件、操作系统、具身智能等概念涨幅居前；核电、离境退税、光刻工厂、军工等概 念跌幅居前。 | | | Wind热门概念指数 | | | | --- | --- | --- | --- | -- ...

Do these photos remind you of something. Maybe your childhood. Haven't you ever wanted some toy as a kid, but your parents said no. Has anyone here wanted some toy that their parents said no to.Gordy, what did you want. BB gun. A BB gun.Huh. I knew somebody was going to say that. Listen.You'll you'll shoot your eye out, kid. Well, for me, it is a PlayStation. But parents and probably many people here thank think think that a PlayStation is bad for your brain development.And yet, your lovable parents are put ...

[Music] As I gasped for air, barely able to move after my 10k run, I thought maybe I'm not built for this. But then I realized pain was giving me a choice. I could kit or I could continue.What if I told you that pain is not our enemy but our greatest teacher. The very thing we spend our lives avoiding could be the thing to unlocking our achievement. We all experience pain physically, emotionally, mentally.But the real question is what if we chose to embrace pain. Could it be the gateway to something greater ...